1
|
Niroomand‐Rad A, Chiu‐Tsao S, Grams MP, Lewis DF, Soares CG, Van Battum LJ, Das IJ, Trichter S, Kissick MW, Massillon‐JL G, Alvarez PE, Chan MF. Report of AAPM Task Group 235 Radiochromic Film Dosimetry: An Update to TG‐55. Med Phys 2020; 47:5986-6025. [DOI: 10.1002/mp.14497] [Citation(s) in RCA: 64] [Impact Index Per Article: 12.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2020] [Revised: 09/15/2020] [Accepted: 09/17/2020] [Indexed: 12/12/2022] Open
Affiliation(s)
| | | | | | | | | | | | - Indra J. Das
- Radiation Oncology Northwestern University Memorial Hospital Chicago IL USA
| | - Samuel Trichter
- New York‐Presbyterian HospitalWeill Cornell Medical Center New York NY USA
| | | | - Guerda Massillon‐JL
- Instituto de Fisica Universidad Nacional Autonoma de Mexico Mexico City Mexico
| | - Paola E. Alvarez
- Imaging and Radiation Oncology Core MD Anderson Cancer Center Houston TX USA
| | - Maria F. Chan
- Memorial Sloan Kettering Cancer Center Basking Ridge NJ USA
| |
Collapse
|
2
|
Crowe SB, Bennett J, Lathouras M, Lancaster CM, Sylvander SR, Chua B, Bettington CS, Lin CY, Kairn T. Impact of radiopacified bone cement on radiotherapy dose calculation. PHYSICS & IMAGING IN RADIATION ONCOLOGY 2020; 14:12-16. [PMID: 33458308 PMCID: PMC7807530 DOI: 10.1016/j.phro.2020.04.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/21/2020] [Revised: 04/22/2020] [Accepted: 04/29/2020] [Indexed: 11/27/2022]
Abstract
Background and purpose Radiopacifiers are introduced to bone cements to provide the appearance of bone in kilovoltage (kV) radiographic images. For higher energy megavoltage (MV) radiotherapy treatment beams, however, these radiopacifiers do not cause a bone-like perturbation of dose. This study therefore aimed to determine the impact of the barium-contrasted plastic-based cement materials on radiotherapy dose calculations. Materials and methods The radiological properties of a physical sample of bone cement were characterised by computed tomography (CT) imaging and transmission measurements. Monte Carlo simulations of percentage depth-dose profiles were performed to determine the possible dose error for MV treatment beams. Dose differences were then investigated for clinical volumetric modulated radiotherapy treatment plans, with and without density overrides applied. Results Differences of up to 7% were observed at the downstream interface of a 0.6 cm thick bone cement layer, compared to bone. Differences in planning target volume dose-volume metrics varied between −0.5% and 2.0%. Conclusion Before planning radiotherapy treatments for patients who have undergone cranioplasty, every effort should be made to identify whether a radiopacified bone cement has been implanted. Density overrides should be applied to minimise dose calculation errors, whenever bone cement is used.
Collapse
Affiliation(s)
- Scott B Crowe
- Cancer Care Services, Royal Brisbane & Women's Hospital, Herston, QLD 4029, Australia.,Science and Engineering Faculty, Queensland University of Technology, Brisbane, QLD 4000, Australia.,Herston Biofabrication Institute, Herston, QLD 4029, Australia
| | - Jane Bennett
- Cancer Care Services, Royal Brisbane & Women's Hospital, Herston, QLD 4029, Australia
| | - Marika Lathouras
- Cancer Care Services, Royal Brisbane & Women's Hospital, Herston, QLD 4029, Australia
| | - Craig M Lancaster
- Cancer Care Services, Royal Brisbane & Women's Hospital, Herston, QLD 4029, Australia
| | - Steven R Sylvander
- Cancer Care Services, Royal Brisbane & Women's Hospital, Herston, QLD 4029, Australia
| | - Benjamin Chua
- Cancer Care Services, Royal Brisbane & Women's Hospital, Herston, QLD 4029, Australia.,Faculty of Medicine, University of Queensland, St. Lucia, QLD 4072, Australia
| | - Catherine S Bettington
- Cancer Care Services, Royal Brisbane & Women's Hospital, Herston, QLD 4029, Australia.,Faculty of Medicine, University of Queensland, St. Lucia, QLD 4072, Australia
| | - Charles Y Lin
- Cancer Care Services, Royal Brisbane & Women's Hospital, Herston, QLD 4029, Australia.,Faculty of Medicine, University of Queensland, St. Lucia, QLD 4072, Australia
| | - Tanya Kairn
- Cancer Care Services, Royal Brisbane & Women's Hospital, Herston, QLD 4029, Australia.,Science and Engineering Faculty, Queensland University of Technology, Brisbane, QLD 4000, Australia
| |
Collapse
|